Pertuzumab, trastuzumab and taxane combination for visceral organ metastatic patients: Real life practice results
| dc.contributor.author | Esin, E. | |
| dc.contributor.author | Oksuzoglu, O. B. Cakmak | |
| dc.contributor.author | Bilici, A. | |
| dc.contributor.author | Cicin, I. | |
| dc.contributor.author | Aksoy, S. | |
| dc.contributor.author | Alacacioglu, A. | |
| dc.contributor.author | Kaplan, M. A. | |
| dc.date.accessioned | 2024-02-23T14:45:11Z | |
| dc.date.available | 2024-02-23T14:45:11Z | |
| dc.date.issued | 2018 | |
| dc.department | NEÜ | en_US |
| dc.description | 43rd ESMO Congress (ESMO) -- OCT 19-23, 2018 -- Munich, GERMANY | en_US |
| dc.description.abstract | [Abstract Not Availabe] | en_US |
| dc.description.sponsorship | European Soc Med Oncol,Japanese Soc Med Oncol | en_US |
| dc.identifier.endpage | 105 | en_US |
| dc.identifier.issn | 0923-7534 | |
| dc.identifier.issn | 1569-8041 | |
| dc.identifier.scopusquality | Q1 | en_US |
| dc.identifier.startpage | 104 | en_US |
| dc.identifier.uri | https://hdl.handle.net/20.500.12452/17299 | |
| dc.identifier.volume | 29 | en_US |
| dc.identifier.wos | WOS:000459277300323 | en_US |
| dc.identifier.wosquality | Q1 | en_US |
| dc.indekslendigikaynak | Web of Science | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Oxford Univ Press | en_US |
| dc.relation.ispartof | Annals Of Oncology | en_US |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | [Keyword Not Available] | en_US |
| dc.title | Pertuzumab, trastuzumab and taxane combination for visceral organ metastatic patients: Real life practice results | en_US |
| dc.type | Conference Object | en_US |












